|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/706 | (2013.01) | ||
| A61K 31/282 | (2006.01) | ||
| A61K 9/0075 | (2013.01) | ||
| A61K 31/706 | (2006.01) | ||
| A61K 9/145 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 47/183 | (2013.01) | ||
| A61K 47/18 | (2006.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61K 31/661 | (2013.01) |
| (11) | Number of the document | 3749298 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19751123.1 |
| Date of filing the European patent application | 2019-02-07 | |
| (97) | Date of publication of the European application | 2020-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/017083 |
| Date | 2019-02-07 |
| (87) | Number | WO 2019/157200 |
| Date | 2019-08-15 |
| (30) | Number | Date | Country code |
| 201862627428 P | 2018-02-07 | US |
| (72) |
BELINSKY, Steven A. , US
KUEHL, Philip J. , US
BADENOCH, Aaron , US
BURKE, Michael , US
DUBOSE, Devon , US
|
| (73) |
Lovelace Biomedical Research Institute ,
2425 Ridgecrest Drive, S.E., Albuquerque, New Mexico 87108,
US
|
| (54) | INHALABLE DRY POWDER CYTIDINE ANALOGUE COMPOSITION AND METHOD OF USE AS A TREATMENT FOR CANCER |
| INHALABLE DRY POWDER CYTIDINE ANALOGUE COMPOSITION AND METHOD OF USE AS A TREATMENT FOR CANCER |